Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, U6 small nuclear 832, pseudogene (RNU6-832P) is a human pseudogene belonging to the family of U6 small nuclear RNA (snRNA) genes[1]. U6 snRNA is an essential component of the spliceosome required for pre-mRNA splicing in eukaryotes[3][5]. However, RNU6-832P is classified as a pseudogene, which means it is a non-functional copy or remnant of a functional gene, generally lacking protein-coding or catalytic activity and often not transcribed into a stable or functional RNA product[1]. While some pseudogenes have been shown to exert regulatory effects or impact disease biology by acting as competing endogenous RNAs or decoys for regulatory molecules, there is currently no evidence that RNU6-832P specifically plays such a role[2]. It is *not* considered a direct therapeutic target, nor does it have known involvement in drug mechanisms or safety concerns.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 832, pseudogene (RNU6-832P).